Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting a conference call today, February 10, ...

Data presented at the 2025 Crohn's and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...

Starting at $61,950 plus on-road costs, the CX-80 Touring is the second of four six-cylinder petrol G40e models, stretching from the $54,950 Pure to the $74,150 Azami via the $68,950 GT (all before on ...